Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19
The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:183 |
---|---|
Enthalten in: |
Ugeskrift for laeger - 183(2021), 35 vom: 30. Aug. |
Sprache: |
Dänisch |
---|
Beteiligte Personen: |
Wolthers, Signe Amalie [VerfasserIn] |
---|
Themen: |
B5S3K2V0G8 |
---|
Anmerkungen: |
Date Completed 09.09.2021 Date Revised 04.12.2021 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM330195786 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM330195786 | ||
003 | DE-627 | ||
005 | 20231225210750.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||dan c | ||
028 | 5 | 2 | |a pubmed24n1100.xml |
035 | |a (DE-627)NLM330195786 | ||
035 | |a (NLM)34477089 | ||
035 | |a (PII)V05210425 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a dan | ||
100 | 1 | |a Wolthers, Signe Amalie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.09.2021 | ||
500 | |a Date Revised 04.12.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
650 | 7 | |a ChAdOx1 nCoV-19 |2 NLM | |
650 | 7 | |a B5S3K2V0G8 |2 NLM | |
700 | 1 | |a Stenberg, Jakob |e verfasserin |4 aut | |
700 | 1 | |a Nielsen, Henning Bay |e verfasserin |4 aut | |
700 | 1 | |a Stensballe, Jakob |e verfasserin |4 aut | |
700 | 1 | |a Pedersen, Henrik Planck |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ugeskrift for laeger |d 1945 |g 183(2021), 35 vom: 30. Aug. |w (DE-627)NLM000011185 |x 1603-6824 |7 nnns |
773 | 1 | 8 | |g volume:183 |g year:2021 |g number:35 |g day:30 |g month:08 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 183 |j 2021 |e 35 |b 30 |c 08 |